✉news BusinessStartups first seen 3 h ago, last 50 min ago, peak #21
OpenAI leads $150M funding round for drug revival startup Biossil
Original: OpenAI leads $150M round for drug-reviving startup Biossil
OpenAI has led a $150 million investment round in Biossil, a startup focused on reviving abandoned drugs. The company specializes in taking discontinued or shelved pharmaceutical compounds and finding new paths to develop them. It is a notable move for OpenAI's investment arm, signaling growing interest in applying AI to drug discovery and development, and fresh attention on the drug-repurposing sector.
Why now: OpenAI's leading role in a major biotech funding round marks an unusual expansion of its activities beyond artificial intelligence software.
Rank over time, top of the chart is #1. 3 snapshots from 3 h ago to 50 min ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/248746